Artículos relacionados a Alzheimers Disease
Book by Murphy Michael F Sramek John J Kurtz Neil M Carta
"Sinopsis" puede pertenecer a otra edición de este libro.
Reseña del editor:
Alzheimer's disease (AD) is a progressively degenerative form of dementia in which impaired cognitive functioning is the earliest and most prominent clinical "symptom". While much has been learned about the disease process itself, progress in treatment has been slow and the search for new and more effective therapies is intensifying rapidly. This book provides a broad scientific readership with a critical assessment of the impact that the next generation of drug treatments in AD will have, based on empirical data from recent and ongoing clinical trials. Information is presented clearly and concisely, and this book should be valuable to any researcher or clinician with an interest in AD.
"Sobre este título" puede pertenecer a otra edición de este libro.
- EditorialGreenwich Medical Media
- Año de publicación2001
- ISBN 10 1841100064
- ISBN 13 9781841100067
- EncuadernaciónTapa dura
- Número de páginas208
Los mejores resultados en AbeBooks
Imagen de archivo
Alzheimer's Disease: Optimizing the Development of the Next Generation of Therapeutic Compounds (Greenwich Medical Media)
Publicado por
Oxford University Press
(1998)
ISBN 10: 1841100064
ISBN 13: 9781841100067
Antiguo o usado
Tapa dura
Cantidad disponible: 1
Librería:
Valoración
Descripción Hardcover. Condición: VG. Text free of underlining, writing and highlighting. Alzheimer's disease (AD) is a progressively degenerative form of dementia in which impaired cognitive functioning is the earliest and most prominent clinical 'symptom'. While much has been learned about the disease process itself, progress in treatment has been slow and the search for new and more effective therapies is intensifying rapidly. This book critically assesses the impact of the next generation of drug treatments in AD. It will serve as a valuable reference source for clinical researchers involved in all aspects of drug development in AD including neurologists, psychiatrists, geriatricians, psychologists, psychopharmacologists, clinical pharmacologists and all those involved in the design and analysis of pharmaceutical trials. ' 208 pages. Nº de ref. del artículo: WBM017345
Comprar usado
EUR 11,30
Convertir moneda